» Articles » PMID: 496998

Domperidone, a Specific in Vitro Dopamine Antagonist, Devoid of in Vivo Central Dopaminergic Activity

Overview
Date 1979 Jul 15
PMID 496998
Citations 70
Authors
Affiliations
Soon will be listed here.
Citing Articles

The methodology for preparing domperidone: strategies, routes and reaction processes.

Yu L, Shao R, Guo Q, Hong H, Zhu N RSC Adv. 2022; 12(35):22869-22880.

PMID: 36105951 PMC: 9377158. DOI: 10.1039/d2ra03777g.


Dopamine D2-Subtype Receptors Outside the Blood-Brain Barrier Mediate Enhancement of Mesolimbic Dopamine Release and Conditioned Place Preference by Intravenous Dopamine.

Obray J, Small C, Baldwin E, Jang E, Lee J, Yang C Front Cell Neurosci. 2022; 16:944243.

PMID: 35903367 PMC: 9314669. DOI: 10.3389/fncel.2022.944243.


Dopamine, Erectile Function and Male Sexual Behavior from the Past to the Present: A Review.

Melis M, Sanna F, Argiolas A Brain Sci. 2022; 12(7).

PMID: 35884633 PMC: 9312911. DOI: 10.3390/brainsci12070826.


The peripheral dopamine 2 receptor antagonist domperidone attenuates ethanol enhancement of dopamine levels in the nucleus accumbens.

Obray J, Jang E, Klomp A, Small C, Richardson A, LeBaron J Alcohol Clin Exp Res. 2022; 46(3):396-409.

PMID: 35040146 PMC: 8920780. DOI: 10.1111/acer.14775.


Review of serum prolactin levels as an antipsychotic-response biomarker.

Gault J, Nussbaum A Open Access J Transl Med Res. 2021; 2(3):84-91.

PMID: 34079927 PMC: 8168627. DOI: 10.15406/oajtmr.2018.02.00043.